Blog

MBMA data curation: How AI and expert meta-analysts get it right, fast

In MBMA, the data layer is the real bottleneck. See how AI and expert meta-analysts…

Matt Zierhut, PhD MBA2026 年 8 月 14 日

Webinar

Transforming drug interaction evaluation workflows with DIDB

Ichiko Petrie, PharmD2026 年 8 月 14 日

Blog

A model-informed approach to radioligand therapy dosing under Project Optimus

Explore how targeted radionuclide therapy dosing uses QSP, biologically effective dose (BED), and exposure-response modeling…

Hunter Stephens, PhD2026 年 8 月 13 日

White Paper

Managing drug-drug interaction (DDI) risk for patients in clinical trials

Discover how DIDB® helps clinical teams assess drug-drug interaction risk, develop prohibited medication lists, &…

Katie Owens, PhD2026 年 8 月 12 日

Live Events

Tailwinds for MIDD: What to Know About the Changing Regulatory Landscape

2026 年 6 月 30 日 - 12:00 PM – 2:00 PM

Certara2026 年 8 月 12 日

Publication

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Explore advances in model-informed precision dosing (MIPD) for pediatric antimicrobial therapy, including population PK modeling,…

Certara2026 年 7 月 29 日

Publication

Conditional activation of IL-12 through a Fibronectin-EDB dependent switch gate

See how QSP modeling guided the design of a reversible antibody switch that unmasks IL-12…

Certara2026 年 7 月 24 日

Poster

Assessing Cross-Version Simcyp Simulator Prediction Performance Using a Bioequivalence Framework to Support EMA Qualification

See how Simcyp Simulator V20–V24 DDI predictions were shown equivalent to the EMA-qualified V19 using…

Certara2026 年 7 月 24 日

Poster

A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans

See how quantitative pharmacology and PBPK modeling supported first in human dose selection for a…

Certara2026 年 7 月 20 日

Publication

Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data

QSP modeling reveals patient-specific factors driving CAR T-cell response and relapse in multiple myeloma, with…

Certara2026 年 7 月 20 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

建模与模拟

MBMA data curation: How AI and expert meta-analysts get it right, fast

Transforming drug interaction evaluation workflows with DIDB

A model-informed approach to radioligand therapy dosing under Project Optimus

Managing drug-drug interaction (DDI) risk for patients in clinical trials

Tailwinds for MIDD: What to Know About the Changing Regulatory Landscape

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Conditional activation of IL-12 through a Fibronectin-EDB dependent switch gate

Assessing Cross-Version Simcyp Simulator Prediction Performance Using a Bioequivalence Framework to Support EMA Qualification

A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans

Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data

订阅时事通讯

快捷链接

解决方案

联系我们